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A striking increase in the numbers of cultures positive for Mycobacterium tuberculosis was noticed in a myco-
bacterial reference laboratory in Campinas, Sao Paulo State, Brazil, in May 1995. A contaminated broncho-
scope was the suspected cause of the increase. All 91 M. tuberculosis isolates grown from samples from patients
between 8 May and 18 July 1995 were characterized by spoligotyping and IS6110 fingerprinting. Sixty-one of
the 91 isolates had identical spoligotype patterns, and the pattern was arbitrarily designated S36. The 61 spec-
imens containing these isolates had been processed and cultured in a 21-day period ending on 1 June 1995, but
only 1 sample was smear positive for acid-fast bacilli. The patient from whom this sample was obtained was
considered to be the index case patient and had a 41 smear-positive lymph node aspirate that had been sent
to the laboratory on 10 May. Virtually all organisms with spoligotype S36 had the same IS6110 fingerprint
pattern. Extensive review of the patients’ charts and investigation of laboratory procedures revealed that cross-
contamination of specimens had occurred. Because the same strain was grown from all types of specimens, the
bronchoscope was ruled out as the outbreak source. The most likely source of contamination was a multiple-
use reagent used for specimen processing. The organism was cultured from two of the solutions 3 weeks after
mock contamination. This investigation strongly supports the idea that M. tuberculosis grown from smear-
negative specimens should be analyzed by rapid and reliable strain differentiation techniques, such as spoligo-
typing, to help rule out laboratory contamination.
The inexorable global increase in tuberculosis cases (1) has
resulted in a substantial rise in the numbers of specimens
cultured in diagnostic mycobacteriology laboratories. This in-
crease and the advent and use of molecular tools to subtype or
fingerprint Mycobacterium tuberculosis have resulted in in-
creased recognition of specimen contamination events linked
either to laboratory procedures or, in rare cases, to contami-
nated bronchoscopes (2–5, 7, 9–13, 15). Generally, contamina-
tion of only a relatively few specimens from patients has been
documented, and this suggests that the number of individuals
detrimentally affected has been small and that the associated
treatment and contact investigation costs have been low. In the
work described here, we used molecular strain typing and
epidemiologic techniques to document an extensive pseudo-
outbreak of tuberculosis involving 60 patients, all of whom
were treated for the disease.
MATERIALS AND METHODS
The mycobacterial laboratory located at the Hospital das Clinicas da Univer-
sidade Estadual de Campinas in Campinas, Sao Paulo State, Brazil, serves an
area with an estimated population of 5 million people. The laboratory receives
about 5,000 to 8,000 specimens each year, and mycobacteria are grown from
5.4% of the specimens. M. tuberculosis complex isolates are identified in approx-
imately 60% of the positive cultures.
One M. tuberculosis isolate was examined from each culture-positive patient
identified during the study period (91 specimens from 91 patients). The speci-
mens positive by culture were bronchoalveolar lavage (n 5 23); sputum (n 5 23);
pleural fluid (n 5 12); urine (n 5 10); stool (n 5 6); lymph node (n 5 4); ascites
fluid (n 5 4); gastric lavage (n 5 3); and synovial fluid, middle ear aspirate, lung
biopsy, pleural biopsy, hepatic biopsy, and bone biopsy (n 5 1 each) specimens.
The patients’ charts were reviewed to identify signs and symptoms associated
with tuberculosis.
Specimen processing was performed in a laminar-flow hood in a biosafety level
3 laboratory. All reagents used in the decontamination protocol were made in
1,000-ml volumes. Sterile pipettes were used to transfer the solutions from the
main stock bottle into individual specimen tubes. All specimens, including nor-
mally sterile material (except cerebrospinal fluid specimens) were decontami-
nated by a standard NaOH procedure. An equal volume of 4% NaOH was added
to the specimen, and the contents were mixed by inversion for 15 min and diluted
with phosphate-buffered saline to a final volume of 50 ml. After centrifugation at
3,000 rpm for 15 min, the supernatant was discarded. The pH of the pellet was
checked by adding a few drops of phenol red and was adjusted to pH 7 with 3 M
HCl. The pellet was then resuspended in a few drops of 0.9% NaCl, and the
sediment was used to prepare Ziehl-Neelsen smears and to inoculate one Lö-
wenstein-Jensen slant. The cultures were incubated at 35°C and were checked for
growth weekly for 8 weeks. The BACTEC radiometric culture method was not
used in this period. The AccuProbe M. tuberculosis test (Gen-Probe Inc., San
Diego, Calif.) was used for species confirmation. The bacteria analyzed were
recovered from frozen Löwenstein-Jensen cultures.
Spoligotyping was performed with a commercially available kit (Isogen Bio-
science BV, Maarssen, The Netherlands) according to the instructions supplied
by the manufacturer. Briefly, the M. tuberculosis direct repeat region (6) was
amplified with primers DRa (biotinylated) and DRb (8). The amplified DNA was
hybridized to a membrane containing 43 oligonucleotide probes derived from the
spacer sequences in the direct repeat region of M. tuberculosis with a 45-lane
blotter (Miniblotter 45; Immunetics, Cambridge, Mass.). The membrane was
incubated with horseradish peroxidase-labeled streptavidin, and hybridization
was detected by enhanced chemiluminescence (ECL Direct Labeling and De-
tection System; Amersham, Arlington Heights, Ill.). IS6110 fingerprinting was
performed by an internationally standardized protocol (14).
RESULTS
The investigation was initiated when an attending physician
noted that all bronchoalveolar lavage specimens cultured in
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the laboratory in May 1995 were reported to be positive for
M. tuberculosis. Concern was raised that a bronchoscope had
not been sterilized properly. However, because molecular typ-
ing techniques were not available to the laboratory at that time
and because there was clinical suspicion of tuberculosis, treat-
ment of these patients was continued.
To conduct a retrospective investigation examining the pos-
sibility of specimen contamination, all M. tuberculosis isolates
obtained between 8 May and 18 July 1995 were characterized
by spoligotyping and IS6110 fingerprinting. Normally the lab-
oratory identifies one to three culture-positive specimens per
week, but for a 3-week period in May this number increased
dramatically (Fig. 1). Ninety-one patients had culture-positive
specimens in the study period. Eleven of the 91 specimens
were smear positive for acid-fast bacilli (AFB).
Seventeen different spoligotypes were identified among the
91 M. tuberculosis isolates (Fig. 2). Sixty-one isolates had a
spoligotype arbitrarily designated S36, and 60 of these isolates
were cultured from specimens processed between 10 May and
1 June 1995. A review of the laboratory records revealed that
only one patient was smear positive. On 10 May a 41 AFB-
positive purulent specimen was obtained from a lymph node
aspirate from this patient, who was considered to be the index
case patient. All other isolates grown from smear-positive
specimens had different spoligotypes.
The results of the spoligotype analysis suggested that the 61
strains with pattern S36 were related by recent clonal descent.
However, M. tuberculosis isolates grouped together on the ba-
sis of spoligotype sometimes can be differentiated by IS6110
fingerprinting (8). In this light, analysis of a random sample
of 53 of the 61 isolates with the S36 spoligotype by IS6110
typing found that 49 of these 53 organisms also had the same
IS6110 fingerprint, arbitrarily designated AK (Fig. 3). Four
isolates with the S36 spoligotype had different IS6110 fin-
gerprints, including two with unique fingerprints. Two speci-
mens had a unique fingerprint mixed with the AK pattern,
suggesting that two M. tuberculosis clones were present in these
samples. IS6110 fingerprint analysis of 17 M. tuberculosis iso-
lates with a spoligotype other than S36 found that none had the
AK fingerprint characteristic of the contaminating organism
(Fig. 3).
A detailed retrospective chart review found that only 19 of
the 91 patients, including the index case patient, had typical
manifestations of tuberculosis (fever, hemoptysis, weight loss,
and good response to treatment). The great majority of pa-
tients (58 of 61) infected with the S36 spoligotype strain did not
have the full spectrum of manifestations.
DISCUSSION
Taken together, the data presented here indicate that labo-
ratory cross-contamination of specimens resulted in a pseudo-
outbreak of tuberculosis that affected 60 patients. Review of
the literature indicated that this is the largest documented
episode of laboratory cross-contamination (2–5, 7, 9–13, 15).
Although the investigation was initiated because of a con-
cern about bronchoscope contamination, molecular character-
ization of cultures revealed that the same strain was grown
FIG. 1. Temporal distribution of culture-positive specimens in the study period. The number of culture requests from 2 May through 18 July 1995 is represented
by bars. Solid and cross-hatched areas, total number of positive cultures; cross-hatched area, strains with spoligotype pattern S36.
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from all types of specimens. Hence, the bronchoscope was
ruled out as the outbreak source. Instead, the most likely cause
of contamination was found to be the procedure used to de-
contaminate specimens. All false-positive cultures were ob-
tained after a highly AFB-positive sample that grew a strain
with the same fingerprint had been processed in the laboratory.
The solutions used in the decontamination procedure were
generally used for approximately 1 month. It is likely that this
organism was inadvertently introduced into one of these re-
agents. Use of the same solution during all of May then re-
sulted in contamination of many specimens processed in that
period. Importantly, we found that M. tuberculosis could be
grown from the phosphate-buffered saline solution and the
0.9% NaCl solution 3 weeks after mock contamination. The
fact that all 244 cerebrospinal fluid specimens were culture
negative is also consistent with the idea that the contaminant
organism was introduced during the specimen decontamina-
tion procedure. (These specimens were cultured directly and
were not decontaminated.) Recognition of the pseudo-out-
break and elucidation of its probable cause have resulted in the
revision of laboratory procedures. For example, all specimens
obtained from sterile body sites are now cultivated without
decontamination. Most importantly, each solution used in the
decontamination protocol is now aliquoted daily from the main
stock container into a smaller vessel.
To avoid an erroneous diagnosis of tuberculosis and the
resulting unnecessary treatment and contact investigation, my-
cobacteriology laboratories should institute strict procedures
to prevent and identify cross-contamination episodes. Excel-
lent guidelines have been provided by Small et al. (12). Al-
though IS6110 analysis is the current standard method for the
differentiation of M. tuberculosis strains, this technique re-
quires a mature culture, is time-consuming, and is available
only in specialized laboratories. Our results suggest that spo-
ligotyping can be used as an initial screening method to rapidly
identify potential episodes of laboratory cross-contamination.
In addition, laboratories should adopt surveillance mecha-
nisms designed to promptly detect and investigate culture-pos-
itive specimens from patients lacking clinical manifestations of
tuberculosis (4).
FIG. 2. Spoligotype patterns identified among M. tuberculosis isolates. Solid squares, hybridization with the designated spacer probe; open squares, lack of
hybridization.
FIG. 3. IS6110 fingerprint patterns obtained for selected M. tuberculosis iso-
lates. Isolates 1 to 4 have fingerprint pattern AK characteristic of the organism
causing the pseudo-outbreak; isolates 5 to 8 have unique fingerprint patterns that
differentiate them from the organism responsible for the pseudo-outbreak.
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